During the first two to four weeks, participants in trials have reported: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort are among the most commonly reported side effects
It also includes eligibility, contraindications, side effects, monitoring, and the reason for treatment
"Melanotan farlig og ulovlig brunfarge" [Melanotan - dangerous and illegal tan] (in Norwegian)
Peptides are hawked claiming all kinds of benefits, including for aging-related conditions, but it is largely profit-driven hype, he says
Appetite reduction is typically one of the earliest effects of retatrutide, often reported within the first one to two weeks of treatment